Core Points - The company has ensured that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1][10][16] - The board and supervisory board have confirmed the authenticity of the quarterly report and accept legal responsibility for its accuracy [2][12][18] - The third-quarter financial report has not been audited [3][9] Financial Data - The company has not made any retrospective adjustments or restatements of previous accounting data [3] - There are no non-recurring profit and loss items applicable for the quarter [3] - The company has reported no changes in major accounting data and financial indicators [4][7] Shareholder Information - The company has disclosed that major shareholders and board members plan to reduce their holdings [6] - The company has undergone a change in controlling shareholders, with the previous agreement expiring [6] Board and Supervisory Meetings - The third supervisory board meeting was held on October 22, 2025, with all members present [11] - The board approved the third-quarter report, confirming its compliance with legal regulations [12][18] - The board meeting also approved amendments to the company’s articles of association, eliminating the supervisory board [22][25] Upcoming Events - The company will hold its first extraordinary general meeting of 2025 on November 13, 2025, to discuss the approved proposals [36][40] - The meeting will include provisions for both on-site and online voting [42][43]
安徽宏宇五洲医疗器械股份有限公司2025年第三季度报告